Sunday, October 30, 2016

TCT: Advantage of Novel DES Over BMS Grows With Time

(MedPage Today) -- For high bleeding risk patients, rationale for BMS continues to shrink
via TCT: Advantage of Novel DES Over BMS Grows With Time
by

No comments:

Post a Comment